Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aspergillus fumigatusand aspergillosis: From basics to clinics
Amir Arastehfar, Agostinho Carvalho, Jos Houbraken, et al.
Studies in Mycology (2021) Vol. 100, Iss. 1, pp. 100115-100115
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

COVID-19-associated fungal infections
Martin Hoenigl, Danila Seidel, Rosanne Sprute, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1127-1140
Open Access | Times Cited: 327
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Martin Hoenigl, Rosanne Sprute, Matthias Egger, et al.
Drugs (2021) Vol. 81, Iss. 15, pp. 1703-1729
Open Access | Times Cited: 293
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology
Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 4, pp. 580-587
Open Access | Times Cited: 187
Microbe‐Mediated Biosynthesis of Multidimensional Carbon‐Based Materials for Energy Storage Applications
Shenghui Shen, Yanbin Chen, Jiancang Zhou, et al.
Advanced Energy Materials (2023) Vol. 13, Iss. 19
Closed Access | Times Cited: 44
Impact of climate change and natural disasters on fungal infections
Danila Seidel, Sebastian Wurster, Jeffrey D. Jenks, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 6, pp. e594-e605
Open Access | Times Cited: 44
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 27
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
Stefan Hatzl, Alexander C. Reisinger, Florian Posch, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 79
The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey
Jon Salmanton‐García, Martin Hoenigl, Jean‐Pierre Gangneux, et al.
The Lancet Microbe (2022) Vol. 4, Iss. 1, pp. e47-e56
Open Access | Times Cited: 66
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models
Michelle Seif, Tamara Katharina Kakoschke, Frank Ebel, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Closed Access | Times Cited: 55
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
Matthias Egger, Linda Bussini, Martin Hoenigl, et al.
Journal of Fungi (2022) Vol. 8, Iss. 4, pp. 390-390
Open Access | Times Cited: 40
The changing epidemiology of fungal infections
Cornelia Lass‐Flörl, Stephan Steixner
Molecular Aspects of Medicine (2023) Vol. 94, pp. 101215-101215
Open Access | Times Cited: 38
Treatment of Invasive Aspergillosis: How It’s Going, Where It’s Heading
Johannes Boyer, Simon Feys, Isabella Zsifkovits, et al.
Mycopathologia (2023) Vol. 188, Iss. 5, pp. 667-681
Open Access | Times Cited: 29
Invasive Aspergillosis and the Impact of Azole-resistance
Davide Bosetti, Dionysios Neofytos
Current Fungal Infection Reports (2023) Vol. 17, Iss. 2, pp. 77-86
Open Access | Times Cited: 25
Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients
Simon Feys, Agostinho Carvalho, Cornelius J. Clancy, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 9, pp. 728-742
Closed Access | Times Cited: 12
Interplay of Cytokines and Chemokines in Aspergillosis
Jata Shankar, R. S. Thakur, Karl V. Clemons, et al.
Journal of Fungi (2024) Vol. 10, Iss. 4, pp. 251-251
Open Access | Times Cited: 9
Strategies for managing fungicide resistance in the Brazilian tropical agroecosystem: Safeguarding food safety, health, and the environmental quality
Paulo Cézar Ceresini, Tatiane Carla Silva, Samara Nunes Campos Vicentini, et al.
Tropical Plant Pathology (2024) Vol. 49, Iss. 1, pp. 36-70
Open Access | Times Cited: 7
Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.
Fabio Palmieri, Angela Koutsokera, Eric Bernasconi, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 27
Genome-scale metabolic modeling of Aspergillus fumigatus strains reveals growth dependencies on the lung microbiome
Mohammad H. Mirhakkak, Xiuqiang Chen, Yueqiong Ni, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Point-of-care testing for viral-associated pulmonary aspergillosis
Robina Aerts, Brice Autier, Maximilian Gornicec, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 24, Iss. 3, pp. 231-243
Open Access | Times Cited: 16
Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations
Matthias Egger, Romuald Bellmann, Robert Krause, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 2167-2178
Open Access | Times Cited: 15
Variability in competitive fitness among environmental and clinical azole-resistant Aspergillus fumigatus isolates
Shu Chen, Guoxing Zhu, Hui‐Ping Lin, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 6
Camel urine as a potential source of bioactive molecules showing their efficacy against pathogens: A systematic review
Ressmi Amina, Raqraq Habiba, Abouddihaj Barguigua
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 5, pp. 103966-103966
Open Access | Times Cited: 5
Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis
Samuel M. Gonçalves, Inês M. Pereira, Simon Feys, et al.
mBio (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 5
Pathogenic Aspergillus spp. and Candida spp. in coastal waters from southern Brazil: an one health approach
Emília Ferreira Andrade, Vanice Rodrigues Poester, Bruna Muradás Esperon, et al.
Brazilian Journal of Microbiology (2025)
Closed Access
Distribution and Epidemiological Characteristics of Clinical Isolates of A. fumigatus in a Hospital from 2021 to 2023: A Retrospective Study
Zeyu You, Ying Yan, Tingting Fu, et al.
Infection and Drug Resistance (2025) Vol. Volume 18, pp. 1199-1208
Open Access
Page 1 - Next Page

Scroll to top